N.Y. Lawmakers Oppose Ban on Race-Day Salix
Tom LaMarra
June 13, 2012
Two New York senators announced June 12 that they do not support a ban on race-day Salix administration.
Two New York senators announced June 12 that they do not support a ban on race-day Salix administration.
The measure would ban the use of furosemide on race-day in graded and listed stakes over a three-year period.
The AGSC supports a ban on all race-day medication in graded stakes race for 2-year-old Thoroughbreds.
Roughly 15 individuals commented on the KHRC Salix phase-out proposal, with only one in support of the measure
Only four Normandy breeding farms are under quarantine for the disease and events are continuing as planned.
The drug, possibly being misused for its anabolic steroid properties, will be severely restricted next year.
Understanding ailments older foals can develop and treatment options increases the patient’s survival chances.
The Salix debate will continue in early June when the KHRC holds a town hall meeting on the topic.
Show officials removed two horses from the show grounds after the animals tested positive for influenza.
No horses at the event have presented any signs of illness, but biosecurity measures have been implemented.
The KHRC will discuss a possible three-year phase-out of race-day furosemide in graded and listed stakes.
Researchers found several links between equine influenza transmission and weather patterns.
Salix is a medication used to prevent exercise-induced pulmonary hemorrhaging, also known as bleeding.
The witnesses all told Congress they don’t believe race-day medication has a place in Thoroughbred racing.
Study of horses with allergies showed a partial remission of allergy signs with nanoparticle administration
The recording of TheHorse.com’s Ask the Vet LIVE event on the horse’s upper respiratory tract from April 19
Stay on top of the most recent Horse Health news with
